These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32074947)

  • 1. Risk Factors for Mortality among Patients with
    Montero MM; López Montesinos I; Knobel H; Molas E; Sorlí L; Siverio-Parés A; Prim N; Segura C; Duran-Jordà X; Grau S; Horcajada JP
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32074947
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Herrera S; Morata L; Sempere A; Verdejo M; Del Rio A; Martínez JA; Cuervo G; Hernández-Meneses M; Chumbita M; Pitart C; Puerta P; Monzó P; Lopera C; Aiello F; Mendoza S; Garcia-Vidal C; Soriano A; Bodro M
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensively drug-resistant Pseudomonas aeruginosa bacteremia in solid organ transplant recipients.
    Bodro M; Sabé N; Tubau F; Lladó L; Baliellas C; González-Costello J; Cruzado JM; Carratalà J
    Transplantation; 2015 Mar; 99(3):616-22. PubMed ID: 25119130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections.
    Samonis G; Vardakas KZ; Kofteridis DP; Dimopoulou D; Andrianaki AM; Chatzinikolaou I; Katsanevaki E; Maraki S; Falagas ME
    Infection; 2014 Aug; 42(4):721-8. PubMed ID: 24912861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
    Recio R; Villa J; Viedma E; Orellana MÁ; Lora-Tamayo J; Chaves F
    Int J Antimicrob Agents; 2018 Aug; 52(2):172-179. PubMed ID: 29621591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of time-to-positivity of blood cultures on mortality in patients with Pseudomonas aeruginosa bacteremia.
    Rolo M; Martín-Higuera MC; Viedma E; Villa J; Mancheño-Losa M; Lora-Tamayo J; Chaves F; Orellana MÁ; Recio R
    J Glob Antimicrob Resist; 2022 Sep; 30():269-275. PubMed ID: 35787987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.
    Alexopoulou A; Vasilieva L; Agiasotelli D; Siranidi K; Pouriki S; Tsiriga A; Toutouza M; Dourakis SP
    World J Gastroenterol; 2016 Apr; 22(15):4049-56. PubMed ID: 27099449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
    Ng TM; Teng CB; Lye DC; Apisarnthanarak A
    Infect Control Hosp Epidemiol; 2014 Jan; 35(1):49-55. PubMed ID: 24334798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates, predictors and mortality of community-onset bloodstream infections due to Pseudomonas aeruginosa: systematic review and meta-analysis.
    Rojas A; Palacios-Baena ZR; López-Cortés LE; Rodríguez-Baño J
    Clin Microbiol Infect; 2019 Aug; 25(8):964-970. PubMed ID: 30995530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
    Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
    Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study.
    López Montesinos I; Gómez-Zorrilla S; Palacios-Baena ZR; Prim N; Echeverria-Esnal D; Gracia MP; Montero MM; Durán-Jordà X; Sendra E; Sorli L; Guerri-Fernandez R; Padilla E; Grau S; Horcajada JP;
    Infect Dis Ther; 2022 Feb; 11(1):335-350. PubMed ID: 34860333
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Ioannou P; Alexakis K; Maraki S; Kofteridis DP
    Antibiotics (Basel); 2023 Mar; 12(4):. PubMed ID: 37107032
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.
    Vidal F; Mensa J; Almela M; Martínez JA; Marco F; Casals C; Gatell JM; Soriano E; Jimenez de Anta MT
    Arch Intern Med; 1996 Oct; 156(18):2121-6. PubMed ID: 8862105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and Risk Factors Associated With Mortality in Consecutive Patients With Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria.
    Santoro A; Franceschini E; Meschiari M; Menozzi M; Zona S; Venturelli C; Digaetano M; Rogati C; Guaraldi G; Paul M; Gyssens IC; Mussini C
    Open Forum Infect Dis; 2020 Nov; 7(11):ofaa461. PubMed ID: 33209951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and risk factors for mortality in cefepime-resistant Pseudomonas aeruginosa bacteremia.
    Su TY; Ye JJ; Hsu PC; Wu HF; Chia JH; Lee MH
    J Microbiol Immunol Infect; 2015 Apr; 48(2):175-82. PubMed ID: 24064286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Microb Drug Resist; 2005; 11(1):68-74. PubMed ID: 15770098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Prognosis of Bloodstream Infection with Carbapenem-Resistant
    Yuan F; Xiao W; Wang X; Fu Y; Wei X
    Infect Drug Resist; 2023; 16():4943-4952. PubMed ID: 37546370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit.
    Zaragoza R; Artero A; Camarena JJ; Sancho S; González R; Nogueira JM
    Clin Microbiol Infect; 2003 May; 9(5):412-8. PubMed ID: 12848754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of bloodstream infections among spinal cord injury patients and impact of multidrug-resistant organisms.
    Saliba M; Saadeh D; Bouchand F; Davido B; Duran C; Clair B; Lawrence C; Annane D; Denys P; Salomon J; Bernard L; Dinh A
    Spinal Cord; 2017 Feb; 55(2):148-154. PubMed ID: 27995941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of adequate initial antimicrobial therapy on mortality in critical patients with Pseudomonas aeruginosa bacteremia].
    González AL; Leal AL; Cortés JA; Sánchez R; Barrero LI; Castillo JS; Álvarez CA
    Biomedica; 2014 Apr; 34 Suppl 1():58-66. PubMed ID: 24968037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.